Details for 2021820408

Up to date per 05.04.2026

Actions

Title / Product Name

OMECAMTIV MECARBIL ZUR BEHANDLUNG VON HERZINSUFFIZIENZ BEI AUSGEWÄHLTEN PATIENTENGRUPPEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2021820408

EP Publication Number

4243825

E-Number

1856193

Language

PCT Number

US21058988

Publication Date

20.09.2023 A

12.11.2025 B1

Registration Date

12.11.2025

AT Publication Date

15.12.2025

Application Date

11.11.2021

Registration Number

Priorities

12.11.2020

202063112995 P

26.02.2021

202163154077 P

11.05.2021

202163187084 P

28.06.2021

202163202873 P

22.07.2021

202163203436 P

IPC

A61K 31/496 20060101AFI20250910BHEP

Maximum Duration of Protection

11.11.2041

Owner

Amgen Inc.One Amgen Center Drive Thousand Oaks, California 91320US

Cytokinetics, Inc.350 Oyster Point Blvd South San Francisco CA 94080US

Representative

No representatives present

Inventor

HONARPOUR, Narimon Thousand Oaks, California 91320-1799US

MALIK, Fady South San Francisco, California 94080US

Information about Fees